Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 2205Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Good clinical practice regulatory inspections: Lessons for Indian investigator sites

Marwah R, Van de Voorde K, Parchman J

Year : 2010| Volume: 1| Issue : 4 | Page no: 151-155

   This article has been cited by
1 Practical Issues in Clinical Inspection Process
Fuyu Song,Xue Qian,Jianming Li,Shein-Chung Chow,Minghuang Hong
Therapeutic Innovation & Regulatory Science. 2019; 53(3): 374
[Pubmed]  [Google Scholar] [DOI]
2 Development of a checklist of quality indicators for clinical trials in resource-limited countries: The French National Agency for Research on AIDS and Viral Hepatitis (ANRS) experience
Mina Hanna,Albert Minga,Paulin Fao,Laurence Borand,Assane Diouf,Jean-Marc Mben,Rita R Gad,Xavier Anglaret,Brigitte Bazin,Geneviève Chene
Clinical Trials. 2013; 10(2): 300
[Pubmed]  [Google Scholar] [DOI]
3 US food and drug administration Indian site inspections: An experience
Arun Bhatt,Murtuza Bughediwala,Natasha D'Souza,Vipul Halbe,Pooja Mahajan,Shweta Narayanswamy,Richa Sharma
Perspectives in Clinical Research. 2012; 3(2): 73
[Pubmed]  [Google Scholar] [DOI]


Read this article